BioSpace News Archive

Business

Bay Area’s Veracyte to Consolidate R&D Into One Department in Realignment

Not only has the company made changes to its R&D division, it is strengthening its sales division as well.

January 8, 2018
·
2 min read
·
Alex Keown
Biotech Bay

3 Small-Cap Biotechs That Have Big News on the Way in 2018

More excitement should lie ahead for these small-cap biotechs this year.

January 8, 2018
·
1 min read
Pharm Country

Bristol-Myers to Take a $3B Tax Hit in Q4 2017

The expense is primarily related to taxes on unremitted offshore earnings, the company said.

January 8, 2018
·
1 min read
Business

REGENXBIO Banks on Strong Gene Therapy Pipeline and Potential Partnerships

Gene therapy treatment is a high risk, high reward venture, but the promises of a therapy developed through these programs could be life-changing for patients.

January 8, 2018
·
4 min read
·
Alex Keown
Week in Review: China Life Science Starts 2018 with $2B Week

Perennial Real Estate of Singapore announced a $1.2B joint venture to develop hospital-centered mixed-use developments in China.

January 8, 2018
·
1 min read
Drug Development

The “Magic Word” That Can Trigger a Drugmaker’s Stock to Soar

A look at the lucky drugs that have been hailed a breakthrough by the FDA.

January 8, 2018
·
1 min read
Business

Pfizer Quits Neuroscience R&D

As a result, the company will cut 300 jobs, primarily in Massachusetts and Connecticut.

January 8, 2018
·
1 min read
Business

Celgene Makes Buy to Cure the Biotech Blues

Will this new buy be enough for Celgene investors?

January 8, 2018
·
1 min read
Business

The Latest Biotech Startups to Watch

A look at the latest startups that have emerged in 2018 so far.

January 8, 2018
·
1 min read
Policy

Bill Ackman and Valeant’s Bumpy Ride

Just before ringing in the new year, Valeant has managed to resolve another crisis.

January 8, 2018
·
1 min read